Find and Pitch Jounalists, Get Your Story Covered

Tags: esketamine quetiapine remission depression depressive disorder

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	Psychedelics for Psych Conditions Made Their Mark in 2023 - 5 months ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - 6 months ago Psilocybin Shows Promise in Treatment-Resistant Bipolar Type II Depression - 6 months ago U.S. Suicides Hit Record High; FDA Reviews Schizophrenia Drug; Psychology of Misinfo - 6 months ago Positive KarXT Blood Pressure Data; ADHD Manufacturing Cover-Up? 'Profound Autism' - 6 months ago
2	Kristina Fiore MedPage Today Director @MedPageToday. Mentor @Report4America. New York HealthcareJournalism	U.S. Attempts to Get Its Xylazine Problem Under Control - 5 months ago If Ketamine Is So Safe, What Happened to Matthew Perry? - 5 months ago
3	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Ketamine and Chronic Pain; Ivermectin Lawsuit and Public Health; JN.1 Keeps Growing - 5 months ago Subcutaneous Alzheimer's Drug May Be on the Horizon - 7 months ago
4	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: Bristol Myers to buy schizophrenia-drug maker; Servier found guilty of fraud - 5 months ago STAT+: Pharmalittle: Eisai reports injectable version of Alzheimer’s drug as effective as IV; Pfizer says combo flu and Covid shot shows strong response - 7 months ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - 8 months ago
5	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	MDMA—aka ecstasy—submitted to FDA as part of PTSD therapy - 5 months ago
6	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	FDA OKs Maintenance Option for High-Risk Neuroblastoma - 5 months ago
7	Wu Nature	Transport and inhibition mechanisms of human VMAT2 - 5 months ago
8	Di Nature	Transport and inhibition mechanisms of human VMAT2 - 5 months ago
9	Sherry Rais Pharmacy Times	Psychedelic-Assisted Therapy: A Novel, Yet Effective Approach to Treating Mental Health Disorders - 5 months ago
10	David Nield Science Alert	Repeated Ketamine Use Fundamentally Changes The Brain's Dopamine System in Mice - 5 months ago

Journalists covering esketamine